| Source: |
| Type: |
| Drug dosage vs efficacy, and actual dosage number of research papers. |
| 7898- | IVT, | Pharmacokinetics and tissue distribution study of Isovitexin in rats by HPLC-MS/MS |
| - | in-vivo, | Nor, | NA |
| 7896- | IVT, | VT, | Molecular targets of vitexin and isovitexin in cancer therapy: a critical review |
| - | Review, | Var, | NA |
| 7819- | JG, | Evaluation of pharmacokinetic, biodistribution, pharmacodynamic, and toxicity profile of free juglone and its sterically stabilized liposomes |
| - | vitro+vivo, | Nor, | NA |
| 1917- | JG, | Inhibition of human leukemia cells growth by juglone is mediated via autophagy induction, endogenous ROS production, and inhibition of cell migration and invasion |
| - | in-vitro, | AML, | HL-60 |
| 4011- | K+, | Sodium and potassium intakes among US adults: NHANES 2003–2008 |
| - | Analysis, | NA, | NA |
| 4005- | K+, | Potassium |
| - | Review, | Nor, | NA | - | Review, | Stroke, | NA |
| 8101- | KAE, | Kaempferol inhibits cell proliferation and glycolysis in esophagus squamous cell carcinoma via targeting EGFR signaling pathway |
| - | vitro+vivo, | ESCC, | KYSE150 | - | vitro+vivo, | ESCC, | Eca109 |
| 8103- | KAE, | The dietary flavonoid kaempferol effectively inhibits HIF-1 activity and hepatoma cancer cell viability under hypoxic conditions |
| - | in-vitro, | HCC, | HUH7 |
| 8058- | KAE, | A randomized, placebo‐controlled trial evaluating the safety of excessive administration of kaempferol aglycone |
| - | Trial, | Nor, | NA |
| 8071- | KAE, | Cellular reprogramming and signaling control by kaempferol in colorectal cancer |
| - | Review, | CRC, | NA |
| 8061- | KAE, | Kaempferol induces apoptosis in ovarian cancer cells through activating p53 in the intrinsic pathway |
| - | in-vitro, | Ovarian, | A2780S | - | in-vitro, | Ovarian, | OVCAR-3 |
| 8063- | KAE, | Kaempferol exerts anti-proliferative effects on human ovarian cancer cells by inducing apoptosis, G0/G1 cell cycle arrest and modulation of MEK/ERK and STAT3 pathways |
| - | in-vitro, | Ovarian, | NA |
| 8064- | KAE, | Kaempferol Inhibits Pancreatic Cancer Cell Growth and Migration through the Blockade of EGFR-Related Pathway In Vitro |
| - | in-vitro, | PC, | MIA PaCa-2 | - | in-vitro, | PC, | PANC1 | - | in-vitro, | PC, | SNU-213 |
| 8074- | KAE, | Dose-dependent tuning of HSP70-Beclin-1 by kaempferol governs autophagy and chemosensitivity |
| - | in-vitro, | SCC, | KYSE150 | - | in-vitro, | SCC, | KYSE450 | - | in-vitro, | CRC, | HCT116 | - | in-vitro, | Liver, | HepG2 | - | in-vitro, | Cerv, | HeLa | - | in-vitro, | Lung, | A549 |
| 8079- | KAE, | Endoplasmic Reticulum Stress-Mediated Apoptosis Induced by Kaempferol in Colorectal Cancer Cells |
| - | in-vitro, | CRC, | DLD1 | - | in-vitro, | Lung, | A549 | - | in-vitro, | Liver, | HUH7 | - | in-vitro, | Cerv, | HeLa |
| 8080- | KAE, | Hepatoprotective Effect of Kaempferol—A Review |
| - | Review, | Nor, | NA |
| 7827- | KAE, | MBS, | Neuroprotective Potential of Mung Bean (Vigna radiata L.) Polyphenols in Alzheimer's Disease: A Review |
| - | Review, | AD, | NA |
| - | Trial, | Nor, | NA |
| 8110- | L-Orn, | L-ornithine supplementation attenuates physical fatigue in healthy volunteers by modulating lipid and amino acid metabolism |
| - | Trial, | Nor, | NA |
| - | Trial, | CRC, | NA |
| - | Trial, | CRC, | NA |
| 8148- | lamb, | Anti-Cancer Effect of Lambertianic Acid by Inhibiting the AR in LNCaP Cells |
| - | in-vitro, | Pca, | LNCaP |
| 8174- | Lap, | Lapatinib: a dual inhibitor of human epidermal growth factor receptor tyrosine kinases |
| 8171- | Lap, | Effects of food on the relative bioavailability of lapatinib in cancer patients |
| - | Trial, | Var, | NA |
| - | Trial, | BC, | NA |
| 8162- | LapC, | Lapachol inhibits glycolysis in cancer cells by targeting pyruvate kinase M2 |
| - | in-vitro, | Melanoma, | MEL526 | - | in-vitro, | Melanoma, | MEL697 | - | in-vitro, | Melanoma, | MEL103 |
| 8177- | Las, | Lasiokaurin Regulates PLK1 to Induce Breast Cancer Cell G2/M Phase Block and Apoptosis |
| - | vitro+vivo, | BC, | MDA-MB-231 |
| 8256- | LCA, | Licochalcone A inhibits the growth of colon carcinoma and attenuates cisplatin-induced toxicity without a loss of chemotherapeutic efficacy in mice |
| - | in-vivo, | Colon, | CT26 |
| 8209- | LCA, | Licochalcone A Exerts Anti-Cancer Activity by Inhibiting STAT3 in SKOV3 Human Ovarian Cancer Cells |
| - | in-vitro, | Ovarian, | SKOV3 |
| 8216- | LCA, | Effects of licochalcone A on the bioavailability and pharmacokinetics of nifedipine in rats: possible role of intestinal CYP3A4 and P-gp inhibition by licochalcone A |
| - | in-vivo, | Nor, | NA |
| 8219- | LCA, | Licochalcone A Ameliorates Cognitive Dysfunction in an Alzheimer's Disease Model by Inhibiting Endoplasmic Reticulum Stress-Mediated Apoptosis |
| - | in-vivo, | AD, | NA |
| 8220- | LCA, | Licochalcone a enhances cognitive resilience in APP/PS1 Mice by modulating glucose metabolism, Aβ burden, and neuroinflammation |
| - | in-vivo, | AD, | NA |
| 8262- | LE, | Phytochemical profiling, antimicrobial, cytotoxic and apoptotic effects of Glycyrrhiza glabra ethanolic extract |
| - | in-vitro, | Liver, | HepG2 |
| 8263- | LE, | Glycyrrhiza glabra L. suppress the proliferation of non-small cell lung cancer by inducing necrosis rather than apoptosis despite increasing bax level |
| - | in-vitro, | Lung, | A549 |
| 8264- | LE, | ISL, | Glycyrrhiza glabra L. Extracts with Potential Antiproliferative and Anti-Migration Activities Against Breast and Gynecological Cancer Cell Lines |
| - | in-vitro, | BC, | MCF7 | - | in-vitro, | BC, | MDA-MB-231 | - | in-vitro, | Melanoma, | A2780S | - | in-vitro, | Cerv, | HeLa |
| 8236- | LE, | Licorice (Glycyrrhiza glabra L.)-Derived Phytochemicals Target Multiple Signaling Pathways to Confer Oncopreventive and Oncotherapeutic Effects |
| - | Review, | Var, | NA |
| 8181- | LEC, | CUR, | Soybean lecithin-stabilized oil-in-water (O/W) emulsions increase the stability and in vitro bioaccessibility of bioactive nutrients |
| - | in-vitro, | Nor, | NA |
| 8145- | LF, | Neuroprotective Effects of Lactoferrin in Alzheimer's and Parkinson's Diseases: A Narrative Review |
| - | Review, | AD, | NA | - | Review, | Park, | NA |
| 8123- | LF, | Effect of orally administered bovine lactoferrin on the growth of adenomatous colorectal polyps in a randomized, placebo-controlled clinical trial |
| - | Trial, | CRC, | NA |
| 8124- | LF, | Inhibition of intestinal polyp growth by oral ingestion of bovine lactoferrin and immune cells in the large intestine |
| - | Trial, | CRC, | NA |
| 8125- | LF, | Talactoferrin alfa versus placebo in patients with refractory advanced non-small-cell lung cancer (FORTIS-M trial) |
| - | Trial, | NSCLC, | NA |
| - | NA, | NSCLC, | NA |
| 8127- | LF, | Phase I trial of oral talactoferrin alfa in refractory solid tumors |
| - | Trial, | Var, | NA |
| 8128- | LF, | Phase 2 trial of talactoferrin in previously treated patients with metastatic renal cell carcinoma |
| - | Trial, | RCC, | NA |
| 8129- | LF, | Study on the Therapeutic Benefit on Lactoferrin in Patients with Colorectal Cancer Receiving Chemotherapy |
| - | Trial, | CRC, | NA |
| 8144- | LF, | A pilot study on the effect of lactoferrin on Alzheimer's disease pathological sequelae: Impact of the p-Akt/PTEN pathway |
| - | Human, | AD, | NA |
| 8142- | LF, | A Randomized, Double-Blind, Controlled Trial to Assess the Effects of Lactoferrin at Two Doses vs. Active Control on Immunological and Safety Parameters in Healthy Adults |
| - | Trial, | Nor, | NA |
| 8200- | LGE, | Chemical Properties and Therapeutic Potential of Citral, a Monoterpene Isolated from Lemongrass |
| - | Review, | Var, | NA |
| 8199- | LGE, | Citral is a new inducer of caspase-3 in tumor cell lines |
| 8195- | LGE, | In Vivo Anti-Tumor Effects of Citral on 4T1 Breast Cancer Cells via Induction of Apoptosis and Downregulation of Aldehyde Dehydrogenase Activity |
| - | vitro+vivo, | BC, | 4T1 |
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:1114 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid